User

About the co-authors

MEGAN ROBERTSON is an Associate in the Health Care and Life Sciences practice, in the Washington, DC, office of Epstein Becker Green. She focuses her practice on health care compliance, fraud and abuse issues, health regulatory due diligence, and medical device product marketing.

Ms. Robertson received her J.D., with honors and with a concentration in Health Law, from The George Washington University Law School. While attending law school, she was the Executive Editor of the Federal Circuit Bar Journal and worked as a Certified Student Attorney at the school’s Vaccine Injury Litigation Clinic. She also served as a legal policy intern at the nonprofit organization Autism Speaks, where she researched coverage of autism therapies in Federal Employee Health Benefit plans and helped draft comments on the proposed rule for the Medicaid managed care regulations.

In 2014, Ms. Robertson graduated, magna cum laude, from Clemson University in South Carolina with a degree in Genetics.

DELIA A. DESCHAINE is a Member of Epstein Becker Green's Health Care and Life Sciences practice, in the firm’s Washington, DC, office. Named to the Washington DC Rising Stars list (2018-2020) in the areas of Food & Drugs and Cannabis Law, Ms. Deschaine understands the most significant U.S. Food and Drug Administration (FDA) and U.S. Drug Enforcement Administration (DEA) legal and compliance risks that her clients face and knows how to address them. Her advice is informed by a background in defending clients in government enforcement actions and challenging unlawful government conduct.